Stephen Connelly's most recent trade in Equillium Inc was a trade of 175,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 175,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 100,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 90,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 52,500 | 52,500 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 52,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 42,534 | 42,534 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 42,534 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Connelly Stephen | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 06 Oct 2021 | 5,625 | 993,000 (5%) | 0% | 7.0 | 39,418 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 5,625 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 06 Oct 2021 | 5,625 | 998,625 (5%) | 0% | 4.8 | 26,719 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 2,467 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 06 Oct 2021 | 2,467 | 993,000 (5%) | 0% | 7.0 | 17,288 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 06 Oct 2021 | 2,467 | 995,467 (5%) | 0% | 2.8 | 6,908 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 04 Jun 2021 | 13,900 | 1,006,900 (5%) | 0% | 4.8 | 66,025 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.14 per share. | 04 Jun 2021 | 13,900 | 993,000 (5%) | 0% | 7.1 | 99,264 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 13,900 | 10,945 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 10,945 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.18 per share. | 04 Jun 2021 | 10,495 | 993,000 (5%) | 0% | 7.2 | 75,315 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 04 Jun 2021 | 10,495 | 1,003,495 (5%) | 0% | 4.7 | 49,851 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 04 Jun 2021 | 8,490 | 1,001,490 (5%) | 0% | 2.8 | 23,772 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.08 per share. | 04 Jun 2021 | 8,490 | 993,000 (5%) | 0% | 7.1 | 60,145 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 8,490 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 04 Jun 2021 | 7,030 | 1,000,030 (5%) | 0% | 4.8 | 33,393 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 04 Jun 2021 | 7,030 | 993,000 (5%) | 0% | 7.0 | 49,245 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 7,030 | 24,845 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 04 Jun 2021 | 6,509 | 999,509 (5%) | 0% | 2.8 | 18,225 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 04 Jun 2021 | 6,509 | 993,000 (5%) | 0% | 7.0 | 45,601 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 6,509 | 8,490 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 28 Dec 2020 | 25,000 | 993,000 (5%) | 0% | 4.5 | 113,045 | Common Stock |
| Equillium Inc | Stephen Connelly | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.62 per share. | 28 Sep 2020 | 25,000 | 1,018,000 (5%) | 0% | 5.6 | 140,395 | Common Stock |